Guideline Concordant Therapy Prolongs Survival in HER2-Positive Breast Cancer Patients: Results from a Large Population-Based Cohort of a Cancer Registry
Inwald, E. C., Ortmann, O., Zeman, F., Koller, M., Hofstädter, F., Gerstenhauer, M. and Klinkhammer-Schalke, M. (2014) Guideline Concordant Therapy Prolongs Survival in HER2-Positive Breast Cancer Patients: Results from a Large Population-Based Cohort of a Cancer Registry. BioMed Research International 2014, pp. 1-10.Date of publication of this fulltext: 19 Dec 2024 08:16
Article
Alternative links to fulltext
Involved Institutions
Details
| Item type | Article | ||||
| Journal or Publication Title | BioMed Research International | ||||
| Publisher: | HINDAWI PUBLISHING CORPORATION | ||||
|---|---|---|---|---|---|
| Place of Publication: | NEW YORK | ||||
| Volume: | 2014 | ||||
| Page Range: | pp. 1-10 | ||||
| Date | 2014 | ||||
| Institutions | Medicine > Lehrstuhl für Frauenheilkunde und Geburtshilfe (Schwerpunkt Frauenheilkunde) | ||||
| Identification Number |
| ||||
| Keywords | ADHERENT ADJUVANT TREATMENT; PHASE-II TRIAL; MULTICENTER COHORT; CLINICAL-ONCOLOGY/COLLEGE; MONOCLONAL-ANTIBODY; AMERICAN-SOCIETY; FOLLOW-UP; TRASTUZUMAB; CHEMOTHERAPY; RECOMMENDATIONS; | ||||
| Dewey Decimal Classification | 600 Technology > 610 Medical sciences Medicine | ||||
| Status | Published | ||||
| Refereed | Yes, this version has been refereed | ||||
| Created at the University of Regensburg | Yes | ||||
| Item ID | 61879 |
Export bibliographical data
Owner only: item control page
Altmetric
Altmetric